Conflicts of Interest in Vaccine Policy Making
Loading...
Serial Number
Levin Center Identifier
OR.106.35
Document Date
2000-08-21
Report Length
46 pages
Policy Agendas Project Major Code
Policy Agendas Project Minor Code
Additional, Minority, Dissenting Views
Report Type
Found Using Methodology
Committee(s)
Subcommittee(s)
Commission(s)
Idependent Author(s)
Brief Executive Summary
The Committee on Government Reform investigated federal vaccine policy to determine the handling of conflicts of interest. The Committee found that the conflict of interest rules have been weak, enforcement has been lax, and committee members with substantial ties to pharmaceutical companies have been given waivers to participate in committee proceedings. Thus, the report recommended that the FDA and CDC be more rigorous in identifying conflicts of interest and adopt stricter standards for the determination of conflicts of interest. Moreover, the Committee recommended that Congress modify existing laws related to conflicts of interest waivers on vaccine-related advisory committees to disallow the granting of waivers for participation and voting by individuals with direct financial ties to affected vaccine-manufacturers.
Press Releases and Contextual Information
Related Hearings
House Committee on Government Reform, hearing on "FACA: Conflicts of Interest and Vaccine Development: Preserving the Integrity of the Process," 106th Cong., H.Hrg. 106-239, (2000, June 15)